1-20 of 493
renal impairment
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prevention and Management of Tumor Lysis Syndrome in Patients with CLL and Coexisting Conditions Treated with Venetoclax-Obinutuzumab or Chlorambucil-Obinutuzumab: Results from the Randomized CLL14 Trial

Free
Othman Al-Sawaf, MD, Anna-Maria Fink, MD, Sandra Robrecht, PhD, Arijit Sinha, PhD, Maneesh Tandon, MD, Barbara F. Eichhorst, MD, Kirsten Fischer, MD, Michael Hallek, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4315.
https://doi.org/10.1182/blood-2019-126570
Published: 2019
Journal Articles

Rivaroxaban Reduces the Levels of Extracellular Vesicles in Patients with Venous Thromboembolism and Non-Valvular Atrial Fibrillation

Free
Sarah Kelliher, MBBS, Luisa Weiss, MSc, Paulina Szklanna, PhD, Karl Egan, PhD, Tadhg Prendiville, MB BCh BAO, Eric Moran, MB BCh BAO, Georgi Petrov, MB BCh BAO, Alfonso Blanco, PhD, Aine Lennon, MSc, Sean Murphy, MD, John Keaney, MD, Fionnuala Ni Ainle, PhD, Patricia Maguire, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2437.
https://doi.org/10.1182/blood-2019-126166
Published: 2019
Journal Articles

Clinical Practice Utilization and Outcomes with Rasburicase Vs Allopurinol for Patients at High Risk of Tumor Lysis Syndrome

Free
Janna Radtchenko, Daniel Lyons, Yvonne Barnes, Scott Milligan, Edward Drea, PharmD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2203.
https://doi.org/10.1182/blood-2019-124319
Published: 2019
Journal Articles

Splenic Marginal Zone Lymphoma: Risk of Transformation, Clinico-Biological Features at Transformation and Prognosis

Free
Gabriela Bastidas, MD, Silvia Bea, PhD, Alba Navarro, Eva Gine, MD, Julio Delgado, Tycho Baumann, Alfredo Rivas-Delgado, MD, Laura Magnano, MD, Neus Villamor, Dolors Costa, MD, Colomer Dolors, Monica Lopez-Guerra, María Rozman, MD, Daniel Martínez, MD, Balagué Olga, Maria Joao Baptista, PhD PharmD, Miguel Alcoceba, Lourdes Escoda, MD, Andrew Wotherspoon, MB BCh, Elias Campo, Armando Lopez-Guillermo, Estella Matutes, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4015.
https://doi.org/10.1182/blood-2019-127199
Published: 2019
Journal Articles

Safety and Efficacy of Autologous Stem Cell Transplantation in Dialysis-Dependent Myeloma Patients - the Diadem Study from the Chronic Malignancies Working Party of the EBMT

Free
Anna Waszczuk-Gajda, MD, Junfeng Wang, PhD, Liesbeth C. de Wreede, PhD, Tiarlan Sirait, MSc, Zubeyde Nur Ozkurt, MD, John A Snowden, BSc (Hons), MBChB, MD FRCP, FRCPath, Peter Dreger, Árpád Illés, MD D.Sc, Mutlu Arat, MD, Claude-Eric Bulabois, MD, Herrad Baurmann, MD, Matjaz Sever, MD PhD, Grzegorz W Basak, MD PhD Professor, Manos Nikolousis, MD, Victoria Potter, MD PhD, Wilfried Schroyens, MD PhD, Emmanuel Gyan, MD PhD, Gwendolyn Van Gorkom, Javier de la Serna, MD, Blandine Guffroy, Patrick J Hayden, MD, Meral Beksac, MD, Stefan O. Schönland, MD, Ibrahim Yakoub-Agha, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4574.
https://doi.org/10.1182/blood-2019-127238
Published: 2019
Journal Articles

Results from an Expanded Access Program of Anti-CD3/CD7 Immunotoxin Combination (T-Guard®) for the Treatment of Steroid-Refractory Acute Gvhd

Free
Lenneke F J Groningen, Christoph Groth, MD, Manita E J Bremmers, Eric G Hooren, Ypke V J M van Oosterhout, Nicole M A Blijlevens, Matthias Stelljes, Walter J F M van der Velden
Journal: Blood
Blood (2019) 134 (Supplement_1): 4553.
https://doi.org/10.1182/blood-2019-122923
Published: 2019
Journal Articles

Hyperphosphatemia Contributes to Inflammation and Iron Dysregulation in Models of Normal and Impaired Renal Function

Free
Brian Czaya, BS, MSc, Beatrice Richter, PhD, Christopher Yanucil, Bsc, Isaac Campos, Bsc, Kylie Heitman, Bsc, Christian Faul, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2238.
https://doi.org/10.1182/blood-2019-122144
Published: 2019
Journal Articles

Optimal - a Study of Bortezomib, Bendamustine and Dexamethasone (BBD) Vs Thalidomide, Bendamustine and Dexamethasone (BTD) in Patients with Renal Failure Defined As an Egfr below 30 Mls/Min

Free
Karthik Ramasamy, MBBS MRCP FRCPath PhD, Mark T Drayson, MB ChB, PhD FRCPath, Gulnaz Iqbal, PhD, Victoria Stalker, BSc, MA, Salma Akhtar, BSc, MSc, Janet Dunn, PhD, Stephen Schey, MBBS
Journal: Blood
Blood (2019) 134 (Supplement_1): 3135.
https://doi.org/10.1182/blood-2019-128157
Published: 2019
Journal Articles

Proton Pump Inhibitors Associated with Higher Incidence of Mucositis in Patients Receiving Methotrexate for Graft Vs Host Disease Prophylaxis

Free
Luke Mountjoy, DO, Daniel Almquist, MD, Henry Ofori, Pharm D, RPh, Marlene Girardo, MS, Margaret McCallen, Pharm D, RPh
Journal: Blood
Blood (2019) 134 (Supplement_1): 3262.
https://doi.org/10.1182/blood-2019-128644
Published: 2019
Journal Articles

Evolving Treatment Trends in Relapsed/Refractory Multiple Myeloma (RRMM) in Europe from 2016 to 2018: Analysis of a Multi-National Survey

Free
Maximilian Merz, Isabelle Vande Broek, MD PhD, Manuel Pérez, Dr., Brigitte Kolb, MD, Argiris Symeonidis, MD PhD, Emmanouil Nikolousis, Athanasios Zomas, Francisco Gonzalez, Lenka Kellermann, BS, MBA, Hartmut Goldschmidt
Journal: Blood
Blood (2019) 134 (Supplement_1): 3115.
https://doi.org/10.1182/blood-2019-122706
Published: 2019
Journal Articles

Depth of Response and Response Kinetics in the Icaria-MM Study of Isatuximab with Pomalidomide/Dexamethasone in Relapsed/Refractory Multiple Myeloma

Free
Cyrille Hulin, MD, Paul G. Richardson, MD, Michel Attal, MD PhD, Hugh J. Goodman, FRACP, Vadim A Doronin, MD, Ivan Spicka, MD PhD Prof, Solenn Le-Guennec, Frank Campana, MD, Helgi van de Velde, MD PhD, Meral Beksac, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3185.
https://doi.org/10.1182/blood-2019-129840
Published: 2019
Journal Articles

Bortezomib-Based Induction and Maintenance Overcomes the Negative Prognostic Impact of Renal Impairment and del17p in Transplant-Eligible Myeloma Patients: Long Term Results from the Phase III HOVON-65/GMMG-HD4 Study after Median 137 Months Follow up

Free
Christof Scheid, MD, Henk Lokhorst, MD PhD, Igor W Blau, MD PhD, Bronno Van Der Holt, PhD, Uta Bertsch, Sonja Zweegman, MD PhD, Katja Weisel, Edo Vellenga, Marie José Kersten, MD PhD, Sandra Croockewit, Elias K Mai, MD, Reinier Raymakers, MD PhD, Dirk Hose, MD, Anna Jauch, Jens Hillengass, MD, Marian Stevens-Kroef, PhD, Marc S Raab, MD PhD, Kai Neben, Stephan Stilgenbauer, Annemiek Broyl, MD PhD, Hans-Walter Lindemann, MD, Gerard Bos, MD PhD, Peter Brossart, MD, Marinus van Marwijk Kooij, MD PhD, Paula F Ypma, MD PhD, Ulrich Dührsen, Prof, MD PhD, Ron Schaafsma, MD PhD, Thomas Hielscher, Hans Salwender, Hartmut Goldschmidt, MD, Pieter Sonneveld
Journal: Blood
Blood (2019) 134 (Supplement_1): 3308.
https://doi.org/10.1182/blood-2019-129684
Published: 2019
Journal Articles

Natural History of Skeletal Related Events in Patients with Multiple Myeloma Who Received First- and Second- Line Therapy with Novel Agents: Results from a Single Center Analysis in 620 Patients

Free
Evangelos Terpos, MD PhD, Nikolaos Kanellias, MD, Eftathios Kastritis, Maria Gavriatopoulou, MD, Vassilis Koutoulidis, MD, Ioannis Ntanasis-Stathopoulos, MD, Aristea-Maria Papanota, MD, Despina Fotiou, MD, Magdalini Migkou, MD, Evangelos Eleutherakis-Papaiakovou, MD, Panagiotis Malandrakis, MD, Tina Bagratuni, PhD, Maria Roussou, MD, Lia A. Moulopoulos, MD, Meletios A. Dimopoulos, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4326.
https://doi.org/10.1182/blood-2019-123606
Published: 2019
Journal Articles

Effect of Cyclophosphamide on Hemorrhagic Cystitis Following Haploidentical Related Compared to Matched Related/Unrelated Donor Hematopoietic Stem Cell Transplantation: A 7-Year Tertiary Center Analysis

Free
Guldane Cengiz Seval, Nergis Ozturk, Sinem Civriz Bozdag, MD, Meltem Kurt Yuksel, MD, Pervin Topcuoglu, MD, Onder Arslan, Muhit Özcan, Taner Demirer, MD, Gunhan Gurman, MD, Osman Ilhan, Hamdi Akan, MD, Meral Beksac, MD, Selami Kocak Toprak, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4504.
https://doi.org/10.1182/blood-2019-127651
Published: 2019
Journal Articles

Infection-Related Morbidity Reduced Overall Survival in a Large Real-World Cohort of Transplant Ineligible Newly Diagnosed Myeloma Patients Treated with UK Standard of Care

Free
Faouzi Djebbari, Fotios Panitsas, Catherine Prodger, Fearn Davies, Kieran Burton, Akhil Khera, Grant Vallance, B.Sc., PhD, Sally Moore, Jaimal Kothari, Andy Peniket, MD, Karthik Ramasamy, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4768.
https://doi.org/10.1182/blood-2019-128139
Published: 2019
Journal Articles

Concomitant Treatment with Ruxolitinib and Deferasirox in the Management of Iron Overload in Patients with Myelofibrosis: A Multicenter Italian Experience

Free
Elena Maria Elli, MD, Ambra Di Veroli, MD, Alessandra Iurlo, MD PhD, Ida Carmosino, Giulia Benevolo, MD, Elisabetta Abruzzese, MD, Massimiliano Bonifacio, MD, Emanuele Sutto, MD, Nicola Polverelli, Marianna Caramella, MD, Daniela Cilloni, MD PhD, Mario Tiribelli, Giovanni Caocci, MD, Elena Crisà, MD, Raffaele Porrini, MD, Rossella Renso, MD, Uros Markovic, MD, Daniele Cattaneo, MD, Lucia Biale, MD, Michela Ansuinelli, MD, Malgorzata Monika Trawinska, MD, Luigi Scaffidi, MD, Massimo Breccia, MD, Carlo Gambacorti-Passerini, MD, Giuseppe A. Palumbo, MD, Roberto Latagliata
Journal: Blood
Blood (2019) 134 (Supplement_1): 839.
https://doi.org/10.1182/blood-2019-127488
Published: 2019
Journal Articles

Efficacy and Safety of Carfilzomib at 56mg/m 2 with Cyclophosphamide and Dexamethasone (K56Cd) in Newly Diagnosed Multiple Myeloma Patients Followed By ASCT or K56Cd Consolidation: Initial Results of the Phase 2 Cardamon Study

Free
Kwee Yong, Rakesh Popat, William Wilson, Gavin Pang, Richard Jenner, Ruth M De Tute, BSc,MSc, Karthik Ramasamy, MBBS MRCP FRCPath PhD, Matthew Streetly, MD, Jamie Cavenagh, MD PhD, Jonathan Sive, MD, Michael Chapman, PhD MRCP, FRCPath, Ceri Bygrave, MD FRCPath, MPhil, Beth Phillips, MBBS, FRCPath, BSc, Selina J Chavda, Andres E. Virchis, FRCP, FRCPath, Reuben Benjamin, FRCPath, MRCP, MBBS, PhD, Sarah Arnott, Fenella Willis, Sandra Hassan, MBBS, MRCP, FRCPath, MDRes), Sally Moore, Laura Clifton-Hadley, PhDBSc, Roger G Owen, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 861.
https://doi.org/10.1182/blood-2019-127992
Published: 2019
Journal Articles

Carfilzomib-Revlimid-Dexamethasone Vs. Carfilzomib-Thalidomide-Dexamethasone Weekly (After 2 Twice Weekly Cycles) Followed By Carfilzomib Maintenance Vs. Control in Transplant Non-Eligible Patients with Newly Diagnosed Multiple Myeloma (NDMM) - Interim Efficacy Analysis of Combined Data (AGMT MM-02)

Free
Heinz Ludwig, MD, Siegfried Sormann, Niklas Zojer, Johannes Andel, Bernd L. Hartmann, Christoph Tinchon, MD, Eberhard Gunsilius, MD, Klaus Podar, MD PhD, Alexander Egle, MD, Wolfgang Willenbacher, MD PhD, Ewald Wöll, MD, Reinhard Ruckser, MD, Boris Bozic, MD, Maria-Theresa Krauth, MD, Andreas Petzer, MD, Clemens A. Schmitt, MD, Sigrid Machherndl-Spandl, MD, Hermine Agis, MD, Bruno Paiva, PhD, Richard Greil, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 696.
https://doi.org/10.1182/blood-2019-127954
Published: 2019
Journal Articles

The Global State of Hematopoietic Stem Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation (WBMT) Database and the Global Burden of Disease Study

Free
Andrew J. Cowan, MD, Helen Baldomero, Yoshiko Atsuta, MD PhD, Joseph Mikhael, MD FRCPC, MD, Mahmoud Aljurf, Adriana Seber, MD, Hildegard T. Greinix, MD, Mickey Koh, MD PhD, Nina Worel, MD, Edward N. Libby, III, MD, Marcelo C. Pasquini, MD, Sebastian Galeano, MD, Gregorio Jaimovich, Juliana Martinez Rolon, MD, Yoshihisa Kodera, MD, Malek Benakli, MD PhD, Bazuaye G Nosakhare, MD, Alaa M. Elhaddad, MD, Jeffrey Szer, MBBS, Jakob R. Passweg, MDMS, Nicolaus Kroeger, MD, Daniel J. Weisdorf, MD, Dietger Niederwieser, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 412.
https://doi.org/10.1182/blood-2019-126837
Published: 2019
Journal Articles

The Effect of Crizanlizumab Plus Standard of Care (SoC) Versus Soc Alone on Renal Function in Patients with Sickle Cell Disease and Chronic Kidney Disease: A Randomized, Multicenter, Open-Label, Phase II Study (STEADFAST)

Free
Kenneth I. Ataga, MD, Santosh L. Saraf, MD, Vimal K. Derebail, MD, Claire C. Sharpe, Adlette Inati, MD, Jeffrey D. Lebensburger, DO, MSPH, Laurie DeBonnett, MD, Shirong Zhang, Pablo Bartolucci, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1018.
https://doi.org/10.1182/blood-2019-124823
Published: 2019